Partial Oral Therapy for Infective Endocarditis Among Adult Infectious Diseases Physicians in the United States: An Emerging Infections Network Survey - Takeaways - MDSpire

Partial Oral Therapy for Infective Endocarditis Among Adult Infectious Diseases Physicians in the United States: An Emerging Infections Network Survey

  • By

  • Jack W McHugh

  • Larry M Baddour

  • Supavit Chesdachai

  • Susan E Beekmann

  • Philip M Polgreen

  • Walter R Wilson

  • Daniel C DeSimone

  • September 15, 2025

  • 0 min

Share

  • 1

    Partial oral therapy (POT) for infective endocarditis (IE) is infrequently used by U.S. adult infectious diseases physicians.

  • 2

    Only 10% of surveyed physicians used POT in more than 25% of their IE cases, indicating limited adoption.

  • 3

    Physicians' comfort with POT varied by pathogen, with 66% comfortable for Streptococcus spp. and only 19% for methicillin-resistant Staphylococcus aureus.

  • 4

    Key barriers to POT adoption included fear of relapse (72%) and adherence concerns (53%), while availability of oral agents was a major facilitator.

  • 5

    There is a strong desire among physicians for clearer guidelines and additional data to support the use of POT in treating infective endocarditis.

Original Source(s)

Related Content